Steven Cohen’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Steven Cohen’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-635,400	Closed	-$12.8M	–	1399
2021 Q3	$12.8M	Sell	635,400 -85,000	-12%	-$2.35M	0.06%	430
2021 Q2	$26.9M	Buy	720,400 +113,961	+19%	+$3.49M	0.12%	222
2021 Q1	$15.5M	Sell	606,439 -1,759,786	-74%	-$44.9M	0.07%	321
2020 Q4	$52.1M	Buy	+2,366,225	New	+$52.1M	0.25%	88
2020 Q2	–	Sell	-1,073,881	Closed	-$19.7M	–	1093
2020 Q1	$19.7M	Sell	1,073,881 -186,335	-15%	-$3.62M	0.16%	184
2019 Q4	$27.8M	Buy	+1,260,216	New	+$25.4M	0.15%	199
2019 Q2	–	Sell	-1,350,000	Closed	-$19.8M	–	1624
2019 Q1	$19.8M	Buy	+1,350,000	New	+$15.5M	0.09%	259
2015 Q2	–	Sell	-600	Closed	-$14K	–	900
2015 Q1	$14K	Buy	+600	New	+$13.5K	﹤0.01%	667

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

Steven Cohen's DRNA Position: Q4 2021 in Review

Steven Cohen sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 635,400 shares — an estimated $12.8M sold.

Steven Cohen first reported a position in DRNA in Q1 2015 and held it in 8 quarters. The position peaked at $52.1M in Q4 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Steven Cohen reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Steven Cohen sold 635,400 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $12.8M.
Steven Cohen first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 8 quarters.
Steven Cohen's Dicerna Pharmaceuticals, Inc. position peaked at $52.1M in Q4 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Point72 Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.